cisplatin can only be administered intravenously, intra-arterially or intraperitoneally. it is usually administered by intravenous drip. adequate hydration treatment is necessary 2 to 16 hours before administration and at least 6 hours after administration.
this product should be diluted with saline or 5% dextrose solution and then intravenously instilled. the dose depends on the effect of chemotherapy and individual response. the following dosages are for reference (for adults and children):
the course of treatment is based on clinical efficacy and is repeated once every 3 to 4 weeks.
this product can be used either in combination therapy with other anticancer drugs, or be used alone.
when used in combination therapy, the dosage should be adjusted as appropriate.
note: please refer to the product manual for details.